Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest COWEN AND COMPANY, LLC Stock Portfolio

$2.58Billion– No. of Holdings #601

COWEN AND COMPANY, LLC Performance:
2024 Q1: 31.65%YTD: 31.65%2023: 3.55%

Performance for 2024 Q1 is 31.65%, and YTD is 31.65%, and 2023 is 3.55%.

About COWEN AND COMPANY, LLC and 13F Hedge Fund Stock Holdings

COWEN AND COMPANY, LLC is a hedge fund based in NEW YORK, NY. On 22-Jun-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $488.6 Millions. In it's latest 13F Holdings report, COWEN AND COMPANY, LLC reported an equity portfolio of $2.6 Billions as of 31 Mar, 2024.

The top stock holdings of COWEN AND COMPANY, LLC are NVDA, COIN, RNA. The fund has invested 26.1% of it's portfolio in NVIDIA CORPORATION and 15.8% of portfolio in COINBASE GLOBAL INC.

The fund managers got completely rid off SELECT SECTOR SPDR TR (XLB), IMPERIAL OIL LTD (IMO) and AVADEL PHARMACEUTICALS PLC (AVDL) stocks. They significantly reduced their stock positions in SCREAMING EAGLE ACQUISITN CO (SCRM), FUTURETECH II ACQUISITION CO (FTII) and ARK ETF TR (ARKF). COWEN AND COMPANY, LLC opened new stock positions in PROTAGONIST THERAPEUTICS INC (PTGX), SUMITOMO MITSUI FINL GROUP I (SMFG) and UROGEN PHARMA LTD (URGN). The fund showed a lot of confidence in some stocks as they added substantially to INNOVIZ TECHNOLOGIES LTD (INVZ), KERNEL GROUP HOLDINGS INC (KRNL) and NABORS ENERGY TRANSITION COR.
COWEN AND COMPANY, LLC Equity Portfolio Value
Last Reported on: 03 May, 2024

COWEN AND COMPANY, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that COWEN AND COMPANY, LLC made a return of 31.65% in the last quarter. In trailing 12 months, it's portfolio return was 44.36%.

New Buys

Ticker$ Bought
protagonist therapeutics inc45,062,400
sumitomo mitsui finl group i32,964,600
urogen pharma ltd24,398,800
spdr s&p 500 etf tr14,935,700
agriculture & nat sol acq co13,566,400
ishares tr12,231,400
quanta svcs inc11,440,800
legato merger corp iii9,883,290

New stocks bought by COWEN AND COMPANY, LLC

Additions

Ticker% Inc.
innoviz technologies ltd14,381
kernel group holdings inc3,473
nabors energy transition cor3,085
bellevue life scncs aqstn co2,248
payoneer global inc1,797
spring valley acquistn corp1,681
moneyhero limited1,671
alpha star acquisition corp1,541

Additions to existing portfolio by COWEN AND COMPANY, LLC

Reductions

Ticker% Reduced
screaming eagle acquisitn co-99.14
futuretech ii acquisition co-96.01
ark etf tr-93.76
plum acquisition corp iii-87.04
sirius xm holdings inc-77.96
immunocore hldgs plc-77.43
generation asia i acquisitio-76.7
engene holdings inc-74.77

COWEN AND COMPANY, LLC reduced stake in above stock

Sold off

None of the stocks were completely sold off by COWEN AND COMPANY, LLC

Sector Distribution

COWEN AND COMPANY, LLC has about 28.5% of it's holdings in Technology sector.

Sector%
Technology28.5
Healthcare22.8
Financial Services19.6
Others18.6
Communication Services6.1
Energy1.6
Basic Materials1.4

Market Cap. Distribution

COWEN AND COMPANY, LLC has about 52.6% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
MEGA-CAP34
LARGE-CAP18.6
UNALLOCATED18.6
SMALL-CAP15.3
MID-CAP10.4
MICRO-CAP2.6

Stocks belong to which Index?

About 0% of the stocks held by COWEN AND COMPANY, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others100
Top 5 Winners (%)%
ATNF
180 life sciences corp
913.0 %
STRC
palladyne ai corp
463.5 %
SMFR
genedx holdings corp
360.4 %
EVGR
evergreen corporation
335.7 %
LGVC
lamf global ventures corp i
299.2 %
Top 5 Winners ($)$
NVDA
nvidia corporation
258.7 M
COIN
coinbase global inc
149.9 M
RNA
avidity biosciences inc
92.7 M
TARS
tarsus pharmaceuticals inc
31.9 M
STOK
stoke therapeutics inc
27.7 M
Top 5 Losers (%)%
BLDE
blade air mobility inc
-70.2 %
SWSS
clean energy spl situations
-67.2 %
PHYT
pyrophyte acquisition corp
-65.1 %
SOND
sonder holdings inc
-63.7 %
FFIE
faraday future intlgt elec i
-63.0 %
Top 5 Losers ($)$
SIRI
sirius xm holdings inc
-6.3 M
LL
ll flooring holdings inc
-3.4 M
RCKT
rocket pharmaceuticals inc
-3.3 M
AAPL
apple inc
-2.8 M
URGN
urogen pharma ltd
-1.7 M

COWEN AND COMPANY, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of COWEN AND COMPANY, LLC

COWEN AND COMPANY, LLC has 601 stocks in it's portfolio. About 67% of the portfolio is in top 10 stocks. SIRI proved to be the most loss making stock for the portfolio. NVDA was the most profitable stock for COWEN AND COMPANY, LLC last quarter.

Last Reported on: 03 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions